Explain this page
Arphra AIPlain-English read on Pfizer Inc.’s valuationNext report
upcomingNo forward estimate on file.
Beat streak
0
consecutive EPS beats
Avg surprise
—
trailing 0q
EPS · actual vs estimate
· earnings_historyactualestimate
No earnings history on file.
Forward consensus
No forward annual estimates on file.
Revenue · actual vs estimate ($B)
No revenue estimate history on file.
Reports tracked
24
Beat rate
0%
0 beats · 12 misses (last 12)
Next report
—
Last report
May 05, 2026
Earnings call transcripts
DB24| Period | Date | Words | Excerpt | |
|---|---|---|---|---|
| FY2026 Q1 | May 05, 2026 | 7,342 | Operator: Good day, everyone, and welcome to Pfizer's First Quarter 2026 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Francesca DeMarti | Read → |
| FY2025 Q4 | Feb 03, 2026 | 10,842 | Francesca DeMartino: Good day, everyone. And welcome to Pfizer Inc.'s Fourth Quarter 2025 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to | Read → |
| FY2025 Q3 | Nov 04, 2025 | 8,541 | Operator: Good day, everyone, and welcome to Pfizer's Third Quarter 2025 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Francesca DeMarti | Read → |
| FY2025 Q2 | Aug 05, 2025 | 11,116 | Operator: Good day, everyone, and welcome to Pfizer's Second Quarter 2025 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Francesca DeMart | Read → |
| FY2025 Q1 | Apr 29, 2025 | 11,818 | Operator: Good day, everyone. And welcome to Pfizer Inc.'s First Quarter 2025 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Francesca De | Read → |
| FY2024 Q4 | Feb 04, 2025 | 10,634 | Operator: Good day, everyone, and welcome to Pfizer's Fourth Quarter 2024 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Francesca DeMart | Read → |
| FY2024 Q3 | Oct 29, 2024 | 13,378 | Operator: Good day, everyone, and welcome to Pfizer's Third Quarter 2024 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Francesca DeMarti | Read → |
| FY2024 Q2 | Jul 30, 2024 | 9,897 | Operator: Good day, everyone, and welcome to Pfizer's Second Quarter 2024 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Francesca DeMart | Read → |
| FY2024 Q1 | May 01, 2024 | 12,824 | Operator: Good day, everyone, and welcome to Pfizer's First Quarter 2024 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Francesca DeMarti | Read → |
| FY2023 Q4 | Jan 30, 2024 | 12,388 | Operator: Good day, everyone, and welcome to Pfizer's Fourth Quarter 2023 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Francesca DeMart | Read → |
| FY2023 Q3 | Oct 31, 2023 | 9,837 | Operator: Good day, everyone, and welcome to Pfizer's Third Quarter 2023 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Mr. Francesca DeM | Read → |
| FY2023 Q2 | Aug 01, 2023 | 13,750 | Operator: Good day, everyone, and welcome to Pfizer’s Second Quarter 2023 Earnings Conference Call. Today’s call is being recorded. At this time, I would like to turn the call over to Mr. Chris Stevo, | Read → |
| FY2023 Q1 | May 02, 2023 | 12,193 | Operator: Good day, everyone, and welcome to Pfizer's First Quarter 2023 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Mr. Chris Stevo, | Read → |
| FY2022 Q4 | Jan 31, 2023 | 12,545 | Operator: Good day, everyone, and welcome to Pfizer’s Fourth Quarter 2022 Earnings Conference Call. Today’s call is being recorded. At this time, I would like to turn the call over to Mr. Chris Stevo, | Read → |
| FY2022 Q3 | Nov 01, 2022 | 11,007 | Operator: Good day, everyone, and welcome to Pfizer's Third Quarter 2022 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Mr. Chris Stevo, | Read → |
| FY2022 Q2 | Jul 28, 2022 | 13,757 | Operator: Good day, everyone, and welcome to Pfizer's Second Quarter 2022 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Mr. Chris Stevo, | Read → |
| FY2022 Q1 | May 04, 2022 | 10,601 | Operator: Greetings, and welcome to the Global Blood Therapeutics Conference Call. At this time all participants are in a listen-only mode. A brief question-and-answer session will follow prepared rem | Read → |
| FY2021 Q4 | Feb 08, 2022 | 16,637 | Operator: Good day, everyone, and welcome to Pfizer's Fourth Quarter 2021 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Mr. Chris Stevo, | Read → |
| FY2021 Q3 | Nov 03, 2021 | 14,261 | Operator: Good day, everyone, and welcome to Pfizer's Third Quarter 2021 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Mr. Chris Stevo, | Read → |
| FY2021 Q2 | Aug 05, 2021 | 8,282 | Operator: Good day, ladies and gentlemen, and welcome to the Arena Pharmaceuticals Second Quarter 2021 Update. At this time all participants are in a listen-only mode. Later we will conduct a question | Read → |
| FY2021 Q1 | May 04, 2021 | 8,017 | Operator: Good day, everyone, and welcome to Pfizer's First Quarter 2021 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Mr. Chuck Triano, | Read → |
| FY2020 Q4 | Feb 02, 2021 | 10,060 | Operator: Good day, everyone, and welcome to Pfizer's fourth-quarter 2020 earnings conference call. Today's call is being recorded. At this time, I would like to turn the call over to Mr. Chuck Triano | Read → |
| FY2020 Q3 | Oct 27, 2020 | 10,214 | Operator: Good day everyone and welcome to Pfizer's Third Quarter 2020 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Mr. Chuck Triano, S | Read → |
| FY2020 Q2 | Jul 28, 2020 | 9,243 | Operator: Good day, everyone, and welcome to Pfizer's Second Quarter 2020 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Mr. Chuck Triano | Read → |
Click Read → for the full transcript with keyword cloud and on-demand AI analyst summary.
Earnings surprises · history
DB · earnings_surprises100% beat2| Period end | Estimate EPS | Actual EPS | Surprise % | Outcome |
|---|---|---|---|---|
| May 05, 2026 | $0.72 | $0.75 | +3.88% | Beat |
| Feb 03, 2026 | $0.57 | $0.66 | +16.40% | Beat |
Surprise history (last 16 quarters)
No surprise data available.
Earnings history
| Date | EPS · est | EPS · actual | Surprise | Revenue · est | Revenue · actual | Result |
|---|---|---|---|---|---|---|
| May 05, 2026 | $0.71 | — | — | $13.84B | — | — |
| Feb 03, 2026 | $0.57 | — | — | $16.85B | — | — |
| Nov 04, 2025 | $0.63 | — | — | $16.5B | — | — |
| Aug 05, 2025 | $0.58 | — | — | $13.56B | — | — |
| Apr 29, 2025 | $0.67 | — | — | $13.92B | — | — |
| Feb 04, 2025 | $0.47 | — | — | $17.35B | — | — |
| Oct 29, 2024 | $0.61 | — | — | $14.92B | — | — |
| Jul 30, 2024 | $0.46 | — | — | $12.96B | — | — |
| May 01, 2024 | $0.52 | — | — | $13.87B | — | — |
| Jan 30, 2024 | $-0.19 | — | — | $14.25B | — | — |
| Oct 31, 2023 | $-0.32 | — | — | $12.72B | — | — |
| Aug 01, 2023 | $0.56 | — | — | $12.08B | — | — |
| May 02, 2023 | $0.98 | — | — | $16.59B | — | — |
| Jan 31, 2023 | $1.05 | — | — | $24.38B | — | — |
| Nov 01, 2022 | $1.39 | — | — | $21.07B | — | — |
| Jul 28, 2022 | $1.78 | — | — | $25.49B | — | — |
Analyst estimates · annual
| Period | EPS · avg | Revenue · avg | # Analysts |
|---|---|---|---|
| No analyst estimates returned. | |||
Analyst estimates · quarterly
| Period | EPS · avg | Revenue · avg | # Analysts |
|---|---|---|---|
| No analyst estimates returned. | |||